psalexa
logo

Cell-Based Assays Market

Cell-Based Assays Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS11093
Available Format:
Category : Biotechnology

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Product

1.3.2. Market Segmentation by Application

1.3.3. Market Segmentation by End User

1.3.4. Market Segmentation by Geography

1.3.5. Analysis Period

1.3.6. Market Data Reporting Unit

1.3.6.1. Value

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participants

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Product

4.1.1.1. Consumables

4.1.1.1.1.    Reagents

4.1.1.1.2.    Assay kits

4.1.1.1.2.1. Reporter gene assays

4.1.1.1.2.2. Cell growth assays

4.1.1.1.2.3. Second messenger assays

4.1.1.1.2.4. Cell death assays

4.1.1.1.2.5. Other assays

4.1.1.1.3. Microplates

4.1.1.1.4. Cell lines

4.1.1.1.4.1. Immortalized cell lines

4.1.1.1.4.2. Primary cell lines

4.1.1.1.4.3. Stem cell lines

4.1.1.1.5.    Probes and labels

4.1.1.1.6.    Other consumables

4.1.1.2. Instruments

4.1.1.3. Services

4.1.1.4. Software

4.1.2. Overview by Application

4.1.2.1. Drug discovery

4.1.2.2. Research studies

4.1.2.3. ADME analysis

4.1.2.4. Predictive toxicology

4.1.2.5. Other applications

4.1.3. Overview by End User

4.1.3.1. Pharmaceutical & biotechnology companies

4.1.3.2. Academic & government institutions

4.1.3.3. Contract research organizations

4.1.3.4. Others

4.2. Market Dynamics

4.2.1. Trends

4.2.2. Drivers

4.2.2.1. Impact analysis of drivers on market forecast

4.2.3. Restraints

4.2.3.1. Impact analysis of restraints on market forecast

4.2.4. Opportunities

4.3. Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Product

5.1. Consumables

5.1.1. Reagents

5.1.2. Assay Kits

5.1.2.1. Reporter gene assays

5.1.2.2. Cell growth assays

5.1.2.3. Second messenger assays

5.1.2.4. Cell death assays

5.1.2.5. Other assays

5.1.3. Microplates

5.1.4. Cell Lines

5.1.4.1. Immortalized cell lines

5.1.4.2. Primary cell lines

5.1.4.3. Stem cell lines

5.1.5. Probes and Labels

5.1.6. Other Consumables

5.2. Instruments

5.3. Services

5.4. Software

Chapter 6. Market Size and Forecast by Application

6.1. Drug Discovery

6.2. Research Studies

6.3. ADME Analysis

6.4. Predictive Toxicology

6.5. Other Applications

Chapter 7. Market Size and Forecast by End User

7.1. Pharmaceutical & Biotechnology Companies

7.2. Academic & Government Institutions

7.3. Contract Research Organizations

7.4. Others

Chapter 8. Market Size and Forecast by Geography

8.1. North America Cell Based Assays Market

8.1.1. By Product

8.1.2. By Application

8.1.3. By End User

8.1.4. By Country – The U.S. and Canada

8.2. Europe Cell Based Assays Market

8.2.1. By Product

8.2.2. By Application

8.2.3. By End User

8.2.4. By Country –  France, The U.K., Germany, Spain, Italy and Rest of Europe

8.3. Asia-Pacific Cell Based Assays Market

8.3.1. By Product

8.3.2. By Application

8.3.3. By End User

8.3.4. By Country – China, Japan, India and Rest of Asia-Pacific

8.4. Latin America Cell Based Assays Market

8.4.1. By Product

8.4.2. By Application

8.4.3. By End User

8.4.4. By Country – Brazil, Mexico and Rest of Latin America

8.5. Middle East & Africa Cell Based (MEA) Assays Market

8.5.1. By Product

8.5.2. By Application

8.5.3. By End User

8.5.4. By Country - UAE, South Africa and Rest of MEA

Chapter 9. Competitive Landscape

9.1. Competitive Analysis of Key Players

9.2. Global Strategic Developments

Chapter 10. Company Profiles

10.1. Becton, Dickinson and Company

10.1.1. Business Overview

10.1.2. Product and Service Offerings

10.1.3. Key Financial Summary

10.1.4. Strategic Growth Plan

10.2. Danaher Corporation

10.2.1. Business Overview

10.2.2. Product and Service Offerings

10.2.3. Key Financial Summary

10.2.4. Strategic Growth Plan

10.3. Thermo Fisher Scientific Inc.

10.3.1. Business Overview

10.3.2. Product and Service Offerings

10.3.3. Key Financial Summary

10.3.4. Strategic Growth Plan

10.4. GE Healthcare Life Sciences

10.4.1. Business Overview

10.4.2. Product and Service Offerings

10.4.3. Key Financial Summary

10.4.4. Strategic Growth Plan

10.5. Merck KGaA

10.5.1. Business Overview

10.5.2. Product and Service Offerings

10.5.3. Key Financial Summary

10.5.4. Strategic Growth Plan

10.6. PerkinElmer Inc.

10.6.1. Business Overview

10.6.2. Product and Service Offerings

10.6.3. Key Financial Summary

10.6.4. Strategic Growth Plan

10.7. Cell Signaling Technologies Inc.

10.7.1. Business Overview

10.7.2. Product and Service Offerings

10.7.3. Key Financial Summary

10.7.4. Strategic Growth Plan

10.8. Promega Corporation

10.8.1. Business Overview

10.8.2. Product and Service Offerings

10.8.3. Key Financial Summary

10.8.4. Strategic Growth Plan

10.9. Cisbio Bioassays

10.9.1. Business Overview

10.9.2. Product and Service Offerings

10.9.3. Key Financial Summary

10.9.4. Strategic Growth Plan

10.10.  Cell Biolabs, Inc.

10.10.1. Business Overview

10.10.2. Product and Service Offerings

10.10.3. Key Financial Summary

10.10.4. Strategic Growth Plan

10.11.   Discoverx Corporation

10.11.1. Business Overview

10.11.2. Product and Service Offerings

10.11.3. Key Financial Summary

10.11.4. Strategic Growth Plan

*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.

Chapter 11. Appendix

11.1. Abbreviations

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry